NeuroLaunch
NeuroLaunch is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at NeuroLaunch.
NeuroLaunch is a company.
Key people at NeuroLaunch.
NeuroLaunch is the world's first accelerator program dedicated to neuroscience startups, founded in 2014 to apply the accelerator model to neurotechnology and brain-related ventures.[1][2][3][5] Its mission is to grow neuroscience ventures shaping humanity's future through direct investments, events, partnerships, and a robust community of startups, innovators, research institutions, and leaders; it has supported over 60 ventures with seed funding, tailored curricula, mentors, and investor access.[1][3][4] NeuroLaunch focuses exclusively on neuroscience and neurotechnology sectors, including neuro-wearables, endovascular devices, genomics platforms, neuroimaging, and clinical trial tools, fostering growth in brain technology startups primarily from regions like the Southeastern U.S., Boston, and Europe.[3]
NeuroLaunch was co-founded in 2014 by Christopher Klaus, a serial entrepreneur, and Dr. Jordan Amadio, a resident physician in neurosurgery at Emory University.[3] The idea emerged to bridge startup accelerator culture with neuroscience, accelerating brain and nervous system innovations amid rising global success of tech accelerators.[1][3] Its inaugural cohort in Fall 2014 selected six promising neuro-startups from over 50 worldwide applications, providing a 90-day curriculum for business validation, mentors, funding, and partnerships—marking a pivotal moment that established it as a pioneer in neuro-innovation.[3]
NeuroLaunch rides the trend of neuroscience converging with business and technology, where brain tech addresses health challenges like stroke, epilepsy, and neurodevelopment amid growing demand for neuro-innovation.[2][3] Timing aligns with the accelerator model's global rise post-2010s, uniquely applying it to neurotech when general programs overlooked brain-focused ventures.[1][3] Market forces favoring it include rising investments in biotech-health intersections and neurodiversity tools, positioning NeuroLaunch to influence the ecosystem by validating models, attracting global talent, and accelerating therapies that streamline trials or enable personalized medicine.[3][6]
NeuroLaunch is poised to expand its community as brain technology frontiers—like AI-driven neuroimaging and accessible neurodiversity assessments—gain traction, potentially scaling investments amid biotech funding surges.[1][3][6] Trends such as gamified neuro-wearables and cloud-based neurosurgery tools will shape its portfolio, evolving its influence from accelerator pioneer to central hub for neuro-venture scaling.[3][4] As the most robust neuroscience startup network, it will continue enabling breakthroughs that redefine human frontiers, building on its 2014 origins to power the next era of brain innovation.[1]
Key people at NeuroLaunch.
